MAPT
MAPT encodes tau, a microtubule-associated protein that stabilizes axonal transport and neuronal polarity. Hyperphosphorylated tau can detach from microtubules and aggregate into neurofibrillary tangles, a major pathology in Alzheimer disease and primary tauopathies.
Key Takeaways
- •MAPT encodes tau, a microtubule-associated protein that stabilizes axonal microtubules and supports transport.
- •Hyperphosphorylated tau can detach from microtubules, mislocalize, and aggregate into neurofibrillary tangles.
- •MAPT mutations cause inherited tauopathies such as FTDP-17, and common haplotypes influence PSP and CBD risk.
- •Tau pathology correlates strongly with cognitive decline in Alzheimer disease and can spread in a prion-like manner.
Basic Information
- Gene Symbol
- MAPT
- Full Name
- Microtubule Associated Protein Tau
- Also Known As
- TauFTDP-17MAPTL
- Location
- 17q21.31
- Protein Type
- Microtubule-associated protein
- Protein Family
- MAP family
Related Isoforms
Key SNPs
Classic marker distinguishing the MAPT H1 and H2 haplotypes; H1 is associated with increased PSP and CBD risk.
Haplotype-linked variant used in studies of tauopathies and neurodegenerative disease risk.
Variant in the H1c sub-haplotype, associated with altered MAPT expression and tauopathy risk.
H1-related locus used in association studies; may tag regulatory variation influencing MAPT expression.
Variant in the MAPT region used to tag haplotype structure and expression quantitative trait loci.
Pathogenic MAPT mutation that promotes tau aggregation and causes autosomal-dominant FTDP-17.
Splicing-affecting mutation that increases 4R tau isoforms and is linked to familial tauopathy.
Overview
MAPT encodes tau, a microtubule-associated protein that stabilizes microtubules in axons and supports long-range transport of mitochondria, vesicles, and synaptic cargo. Tau function depends on a delicate balance of phosphorylation and binding to microtubules, which shifts with development, neuronal activity, and cellular stress.
Tau pathology begins when tau becomes excessively phosphorylated, detaches from microtubules, and mislocalizes from axons into the soma and dendrites. Mislocalized tau can form oligomeric seeds and fibrils that assemble into neurofibrillary tangles. In Alzheimer disease and other tauopathies, tau burden correlates strongly with clinical decline.
Conceptual Model
A simplified mental model for the pathway:
Oligomeric and seeding-competent tau species can be more directly toxic than large, late-stage inclusions.
Core Health Impacts
- • Axonal stability: Stabilizes axonal microtubules and supports long-range transport.
- • Neuronal polarity: Coordinates neuronal polarity by maintaining axon structure and trafficking.
- • Signaling tuning: Phosphorylation state tunes microtubule binding and localization.
- • Synaptic health: Pathological aggregation disrupts synapses and activates glial stress responses.
- • Cognitive tracking: Tangle burden correlates strongly with cognitive decline in Alzheimer disease.
Protein Domains
N-terminal projection
Extends away from microtubules and influences spacing, interactions, and localization.
Proline-rich region
Contains many phosphorylation sites; kinase-phosphatase balance here influences detachment.
Binding repeats
Repeat domains bind microtubules; mutations here affect 3R and 4R isoform aggregation.
Upstream Regulators
GSK3β Activator
Major tau kinase that phosphorylates tau at multiple sites, increasing aggregation propensity.
CDK5 Activator
Stress-driven dysregulation can increase tau phosphorylation and contribute to neurodegeneration.
PP2A Inhibitor
Major tau phosphatase; reduced activity increases net tau phosphorylation.
Amyloid-beta Activator
Upstream amyloid pathology can activate kinase cascades that promote tau spread.
Neuroinflammation Activator
Cytokines and microglial activation can promote tau pathology.
Autophagy Inhibitor
Aging-related decline in autophagy reduces clearance of misfolded tau species.
Downstream Targets
Microtubules Activates
Tau binds and stabilizes microtubules in axons; hyperphosphorylation reduces binding.
Axonal transport Activates
Loss of microtubule integrity disrupts trafficking of mitochondria and synaptic components.
Synapses Inhibits
Mislocalized tau can accumulate in dendrites and synapses, impairing plasticity.
Neurofibrillary tangles Activates
Aggregated tau forms paired helical filaments and tangles linked to clinical decline.
Glia Activates
Extracellular tau species can activate glia and propagate inflammation.
Apoptosis Activates
Downstream responses to tau aggregation include mitochondrial dysfunction and cell death.
Role in Aging
Aging is the strongest risk factor for tau pathology. With age, kinase and phosphatase balance can drift, axonal transport weakens, and clearance pathways decline.
Kinase drift
Aging can shift signaling toward higher net phosphorylation, increasing the probability of tau detachment from microtubules.
Transport decline
Weaker axonal transport reduces delivery of mitochondria and synaptic cargo, increasing vulnerability of long projection neurons.
Autophagy decline
Reduced lysosomal function and autophagy capacity limit clearance of misfolded tau and can increase the lifetime of seeds.
Sleep and clearance
Poor sleep and reduced glymphatic flux may increase persistence of extracellular tau species and inflammatory signaling.
Inflammaging
Chronic low-grade inflammation lowers the threshold for glial activation and can accelerate tau spread.
Vascular vulnerability
Small vessel disease and blood-brain barrier changes can interact with tau pathology and worsen cognitive trajectories.
Disorders & Diseases
Alzheimer Disease
Tau tangles and tau burden correlate strongly with cognitive decline in AD. Tau spread is closely linked to symptom severity.
FTDP-17
Pathogenic MAPT mutations cause autosomal-dominant frontotemporal dementia with parkinsonism.
Progressive Supranuclear Palsy
A primary 4R tauopathy characterized by postural instability. The MAPT H1 haplotype increases risk.
Corticobasal Degeneration
A 4R tauopathy with asymmetric motor features. MAPT region variation influences risk.
CTE
Repetitive head impacts are associated with tau pathology in characteristic cortical patterns.
Interventions
Supplements
Support synaptic membranes and may reduce neuroinflammatory tone that can amplify tau pathology.
Polyphenol studied for anti-aggregation and anti-inflammatory effects relevant to amyloid.
Green tea catechins studied for potential inhibition of protein aggregation.
Supports sleep quality and excitability balance, indirectly supporting cognitive resilience.
Immune-modulating hormone with associations to cognition and inflammation control.
Lifestyle
Supports vascular health and reduces inflammatory burden, which can influence neurodegeneration.
Sleep supports waste clearance and may reduce net accumulation of aggregation-prone tau species.
Managing blood pressure, glucose, and lipids reduces vascular contributions to cognitive impairment.
Builds cognitive reserve and can delay functional impact even when pathology is present.
Medicines
Experimental immunotherapies designed to bind extracellular tau species and reduce spread.
Investigational agents aimed at reducing fibril formation and seeding of tau assemblies.
In Alzheimer disease, reducing amyloid may lower kinase pressure that accelerates tau spread.
Cholinesterase inhibitor used for symptomatic support of cognition in Alzheimer disease.
Lab Tests & Biomarkers
Genetic Testing
Clinical sequencing identifies pathogenic mutations linked to inherited tauopathies like FTDP-17.
Common MAPT haplotypes (H1/H2) influence risk for primary tauopathies such as PSP and CBD.
Fluid Biomarkers
Phosphorylated tau species in blood track Alzheimer-related tau biology early in disease.
CSF tau measures can reflect neurodegeneration and tau phosphorylation state.
Non-specific marker of axonal injury, useful for tracking rate of neurodegeneration.
Imaging
PET ligands can visualize tau burden in vivo, helping stage disease biology.
Regional atrophy patterns can suggest tauopathy subtype and track progression.
Hormonal Interactions
Estrogen Neuroprotective
May influence kinase signaling and synaptic resilience, intersecting with tau pathology.
Cortisol Stress Factor
Chronic elevation can worsen sleep and amplify neuroinflammatory signaling.
Insulin Metabolic Link
Brain insulin resistance is associated with impaired proteostasis and tau phosphorylation.
Melatonin Circadian Lead
Supports sleep architecture, which is linked to brain clearance and resilience.
Deep Dive
Network Diagrams
Tau Detachment and Aggregation
Tau Seeding and Network Spread
Biological Role: From Microtubule Binding to Tangle
Tau normally stabilizes microtubules in axons. Pathology emerges when tau becomes excessively phosphorylated, detaches from microtubules, and mislocalizes into compartments where it can form oligomers and fibrils.
Detachment: Kinase activation (such as GSK3β) and reduced phosphatase activity increase net phosphorylation, weakening tau microtubule binding.
Mislocalization: Tau shifts from axons into the soma and dendrites, disrupting synapses and local signaling.
Seeding and fibrils: Oligomeric tau species can seed additional tau, forming fibrils that accumulate as neurofibrillary tangles.
Seeding and Spread Through Neural Circuits
Misfolded tau can move between connected neurons. Once internalized, tau seeds can template further misfolding and propagate pathology along networks that support memory and executive function.
Release and uptake: Tau species can be released to extracellular space and taken up by neighboring cells via endocytosis and other mechanisms.
Template amplification: Seed-competent tau assemblies can accelerate misfolding of soluble tau in recipient cells, supporting network-level progression.
Isoforms and Splicing: 3R and 4R Tau
MAPT produces multiple tau isoforms through alternative splicing. A key axis is the balance between 3-repeat and 4-repeat microtubule-binding domains. Several FTDP-17 mutations alter splicing, shifting the 3R to 4R ratio and increasing aggregation propensity.
Different tauopathies have characteristic isoform compositions and filament structures, which may explain differences in regional vulnerability and clinical phenotypes.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
Early evidence that tau is a core component of neurofibrillary tangles.
Landmark paper linking MAPT mutations to familial frontotemporal dementia.
Resolved the core fold of tau filaments in Alzheimer disease.
Evidence for prion-like spreading of tau pathology in vivo.